Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
15 results
- 2상조기 종료· HER2-positive Metastatic Breast CancerHER2 Molecular Imaging With 89Zr-trastuzumab PET/CT as a Predictive Biomarker for Antibody-drug Conjugate Sequencing in Patients With Advanced HER2-positive Breast Cancer
협력: 로슈
- 2상조기 종료· Alzheimer's DiseaseEfficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease
리드: GSK
- 2상조기 종료· Melanoma, UvealLenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma
협력: 머크(MSD)
- 2상조기 종료· Microsatellite Stable Metastatic Colorectal CancerA Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer
협력: 일라이 릴리, 머크(MSD)
- 2상조기 종료· Marginal Zone LymphomaPembrolizumab in MarginalzoneLymphoma A MULTICENTER OPEN LABEL SINGLE-ARM PHASE II STUDY
협력: 셀트리온
- 2상조기 종료· Non-Small Cell Lung Cancer MetastaticStaggered, Chemo-Immunotherapy With Durvalumab, MEDI4736 Pemetrexed & Carboplatin (PC) for Metastatic Non-Squamous NSCLC
협력: 아스트라제네카
- 2상조기 종료· Treatment Related CancerOptimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS Mutation
협력: 암젠
- 2상조기 종료· Cmv CongenitalRandomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants
협력: 로슈
- 2상조기 종료· Functional DyspepsiaA Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia
리드: 유한양행
- 2상조기 종료· Non Small Cell Lung CancerPhase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the Lung
리드: 한미약품
- 2상조기 종료· Adenocarcinoma of Lung Stage IIIBNOV120101 (Poziotinib) for 1st Line Monotherapy in Patients With Lung Adenocarcinoma
협력: 한미약품
- 2상조기 종료· Cerebral InfarctionThe Efficacy and Safety Study of ALbumin Therapy in Acute Ischemic Stroke
협력: GC녹십자
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.